Skip to content

Correlation between clinical features and laboratory parameters in adult patients having atopic dermatitis

Correlation between clinical phenotypes and endotypes in a cohort of adult patients having atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053581
Enrollment
150
Registered
2023-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: not applicable: not applicable

Sponsors

Society for eczema Studies
Lead Sponsor
Post Graduate Institute of Medical Education and Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: (a)Age at presentation equal to or more than 18 years (b)Active atopic dermatitis diagnosis of which shall be made on 2 grounds 1. Fulfilment of Hanifin and Rajkaâ??s original criteria 2. Expert opinion where 3 independent eczema experts decide unanimously on the diagnosis of adult AD

Exclusion criteria

Exclusion criteria: (a)Pregnancy and lactation (b)Any immunocompromised state (c)Patients with a history or physical exam suggestive of other causes of eosinophilia common in our settings-helminthic infection, DRESS(drug reaction with eosinophilia and systemic symptoms), bullous pemphigoid, chronic bullous disease of childhood , fungal infections, chronic pancreatitis, primary gastrointestinal eosinophilic disorders including inflammatory bowel disease, eosinophilic esophagitis, coeliac diseases, rheumatological disease-systemic lupus erythematosus, eosinophilic fasciitis (Shulman disease) , vasculitis - polyarteritis nodosa and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), rheumatoid arthritis and acute and chronic eosinophilic pneumonia (that includes Loeffler syndrome, sarcoidosis, allergic bronchopulmonary aspergillosis)

Design outcomes

Primary

MeasureTime frame
Classification of clinical characteristics of adult patients having AD into the following four subgroups as mentioned below 1.High IgE & Eosinophilia 2.Normal IgE & Eosinophilia 3.High IgE and Normal Eosinophils 4.Normal IgE and Normal Eosinophils Timepoint: 1.5 years

Secondary

MeasureTime frame
IL-4 levels in the different subgroupsTimepoint: 1.5 years

Countries

India

Contacts

Public ContactDr Manavi Gupta

Post Graduate Institute of Medical Education and Research

dranha14@gmail.com8872348999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026